| Trial name or title |
Mifepristone induction for fetal demise, a randomised control trial |
| Methods |
Double‐blinded, randomised controlled trial with 1:1 allocation of mifepristone or placebo at initiation of induction of labour for fetal demise 20 weeks estimated gestational age or greater. |
| Participants |
Inclusion criteria
Intrauterine fetal death as confirmed by absence of cardiac motion on ultrasound by attending physician at the time of admission to the hospital. Estimated gestational age greater than 20 weeks Haemodynamically stable and appropriate for induction of labour as per primary clinical health team in house Women with 1 prior low transverse caesarean delivery
|
| Interventions |
Interventional arm: ingest 200 mg tablet of mifepristone orally. Control arm: ingest a placebo tablet orally with similar physical properties. |
| Outcomes |
Time to delivery of fetus [time frame: from the initiation of medical therapy for induction to delivery of fetus] |
| Starting date |
February 2016 |
| Contact information |
Montefiore medical centre, principal investigator: Jessica Atrio, MD, jatrio@montefiore.org |
| Notes |
|
